# Insud Pharma

> Insud Pharma is a VC fund in Madrid backing SaaS and AgTech. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Madrid, Spain
- Total investments: 3
- Last investment: Aug 2022
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://in.linkedin.com/company/insud-pharma
- X (Twitter): https://twitter.com/insudpharma?lang=en
- Website: https://www.insudpharma.com/

Insud Pharma is a global pharmaceutical group that offers CDMO and CMO services and operates end‑to‑end across the entire value chain, from research and development to the manufacturing and commercialization of APIs, FDFs, and branded medicines for human and animal health.

## Contacts

5 contacts available for Insud Pharma. Shizune tracks 3 team members at Insud Pharma. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/insud-pharma?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| SaaS | 1 | 33% |
| AgTech | 1 | 33% |
| Shipping | 1 | 33% |
| Software | 1 | 33% |
| Logistics | 1 | 33% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Argentina | 2 | 67% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr. Hugo Sigman | Founder | 0 | https://shizune.co/investors/profile/dr-hugo-sigman |
| Lucas Sigman | CEO | 0 | https://shizune.co/investors/profile/lucas-sigman-96e3 |
| Silvia Gold | Founder | 0 | https://shizune.co/investors/profile/silvia-gold |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Greenlight Biosciences | GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower cost and more quickly than was ever before possible. GreenLight develops RNA products and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, plant protection andsupport the health of bees and other pollinators. | $109M | Post-IPO Equity | Aug 12, 2022 |  |
| Choiz | Choiz offers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. Built for patients by patients, we are making specialized care and treatment accessible to everyone | $1.5M | Seed | Jul 01, 2022 |  |
| Moova | Moova is a technological platform that captures idle last mile logistic capacity and transforms it into high efficiency and low cost shipping solutions. The platform connects E-Commerce and retail businesses with a fleet of "Moovers" who complete deliveries on their bicycle, motorcycle, car or van to generate an additional source ofincome. Through route optimization software, real-time traceability, flexible warehousing, and analytics, Moova is propelling the nascent E-Commerce industry in Latin America by reimagining the last mile for a sustainable world. | $10M | Series A | Jun 14, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund, 2 deals together
- [Kalei Ventures](https://shizune.co/investors/profile/kalei-ventures) — VC Fund, 2 deals together
- [Movile](https://shizune.co/investors/profile/movile-latin-america) — VC Fund, 2 deals together
- [Alaya Capital](https://shizune.co/investors/profile/alaya-capital) — VC Fund, 1 deal together
- [Continental Grain Company](https://shizune.co/investors/profile/continental-grain-company) — VC Fund, 1 deal together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Newtopia VC](https://shizune.co/investors/profile/newtopia-vc) — VC Fund
- [NXTP Ventures](https://shizune.co/investors/profile/nxtp-ventures) — VC Fund
- [Alaya Capital](https://shizune.co/investors/profile/alaya-capital) — VC Fund

## Featured in investor lists
- [All VC Funds in Argentina](https://shizune.co/investors/vc-funds-argentina)
- [Health Care Investors in Argentina](https://shizune.co/investors/health-care-investors-argentina)
- [Health Care VC Funds in Argentina](https://shizune.co/investors/health-care-vc-funds-argentina)
- [Marketplace VC Funds in Argentina](https://shizune.co/investors/marketplace-vc-funds-argentina)
- [Transportation Investors in Argentina](https://shizune.co/investors/transportation-investors-argentina)

## FAQ

### What does Insud Pharma invest in?

Insud Pharma invests primarily in SaaS, AgTech and Shipping startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Argentina. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Insud Pharma?

Public channels for Insud Pharma include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Insud Pharma?

The team at Insud Pharma includes Dr. Hugo Sigman (Founder), Lucas Sigman (CEO) and Silvia Gold (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co